Itta MacNevin

Itta MacNevin is a seasoned commercial leader with more than two decades of expertise in the life sciences sector. She holds a B.S. in Chemistry from the University of Richmond and an M.S. in Organic Chemistry from Emory University. In her current role, she leads Quibim's global commercial strategy within the life sciences sector, overseeing business development, partnerships and go-to-market execution.

Prior to joining Quibim, she spent 10 years at Evotec, where she held various senior leadership roles focused on commercial strategy and business development. Before her tenure at Evotec, she spent a decade at Scynexis, where she was instrumental in driving strategic growth and partnerships from the company's early stages. Her earlier career includes consulting for Pharmasset, research at Emory University, and studies at the University of Richmond.

Career history

• Chief Business Officer at Quibim (April 2026–present)
• Senior leadership roles at Evotec (2015–2026), including Senior Vice President of Business Development
• Multiple roles at Scynexis (2005–2015), including Business Development Specialist and Innovation Project Leader
• Consultant at Pharmasset and research positions at Emory University and University of Richmond

What Itta MacNevin could bring to Chief Business Officer at Quibim: With her proven track record scaling commercial strategies across pharmaceutical and biotech organizations, MacNevin is positioned to accelerate Quibim's global commercial reach and deepen partnerships with pharmaceutical and biotechnology partners in the precision medicine and AI-driven imaging biomarker space. Her expertise in building high-impact partnerships and navigating complex markets should strengthen the company's go-to-market execution for its oncology, immunology, and neurology platforms.